相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。APOE genotype regulates pathology and disease progression in synucleinopathy
Albert A. Davis et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Effect of escitalopram on Aβ levels and plaque load in an Alzheimer mouse model
John R. Cirrito et al.
NEUROLOGY (2020)
Tau pathology associates with in vivo cortical thinning in Lewy body disorders
Nicola Spotorno et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2020)
An increased rate of longitudinal cognitive decline is observed in Parkinson's disease patients with low CSF Aβ42 and an APOE ε4 allele
Marian Shahid et al.
NEUROBIOLOGY OF DISEASE (2019)
Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders
David Coughlin et al.
ANNALS OF NEUROLOGY (2019)
Parkinson's disease and multiple system atrophy have distinct α-synuclein seed characteristics
Tritia R. Yamasaki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies
Kurt A. Jellinger
JOURNAL OF NEURAL TRANSMISSION (2018)
The limbic and neocortical contribution of α-synuclein, tau, and amyloid β to disease duration in dementia with Lewy bodies
Tanis J. Ferman et al.
ALZHEIMERS & DEMENTIA (2018)
Correlation between decreased CSF α-synuclein and Aβ1-42 in Parkinson disease
Chandana Buddhala et al.
NEUROBIOLOGY OF AGING (2015)
Dopaminergic, serotonergic, and noradrenergic deficits in Parkinson disease
Chandana Buddhala et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)
Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease
Helene Hall et al.
BRAIN (2014)
A quantitative study of α-synuclein pathology in fifteen cases of dementia associated with Parkinson disease
Richard A. Armstrong et al.
JOURNAL OF NEURAL TRANSMISSION (2014)
G51D α-Synuclein mutation causes a novel Parkinsonian-pyramidal syndrome
Suzanne Lesage et al.
ANNALS OF NEUROLOGY (2013)
Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease
Silke Appel-Cresswell et al.
MOVEMENT DISORDERS (2013)
A NOVEL α-SYNUCLEIN MISSENSE MUTATION IN PARKINSON DISEASE
Christos Proukakis et al.
NEUROLOGY (2013)
Binding of the Radioligand SIL23 to α-Synuclein Fibrils in Parkinson Disease Brain Tissue Establishes Feasibility and Screening Approaches for Developing a Parkinson Disease Imaging Agent
Devika P. Bagchi et al.
PLOS ONE (2013)
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach
Thomas J. Montine et al.
ACTA NEUROPATHOLOGICA (2012)
Neuropathologic substrates of Parkinson disease dementia
David J. Irwin et al.
ANNALS OF NEUROLOGY (2012)
Pathologic Accumulation of α-Synuclein and Aβ in Parkinson Disease Patients With Dementia
Paul T. Kotzbauer et al.
ARCHIVES OF NEUROLOGY (2012)
Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?
Yaroslau Compta et al.
BRAIN (2011)
Autopsy consent, brain collection, and standardized neuropathologic assessment of ADNI participants: The essential role of the Neuropathology Core
Nigel J. Cairns et al.
ALZHEIMERS & DEMENTIA (2010)
CSF amyloid β 1-42 predicts cognitive decline in Parkinson disease
A. Siderowf et al.
NEUROLOGY (2010)
Parkinson Disease With Dementia Comparing Patients With and Without Alzheimer Pathology
Marwan N. Sabbagh et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2009)
Neuroanatomical Substrate of Visuospatial and Visuoperceptual Impairment in Parkinson's Disease
Joana B. Pereira et al.
MOVEMENT DISORDERS (2009)
Dementia and visual hallucinations associated with limbic pathology in Parkinson's disease
M. E. Kalaitzakis et al.
PARKINSONISM & RELATED DISORDERS (2009)
Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease
Kurt A. Jellinger et al.
ACTA NEUROPATHOLOGICA (2008)
Cortical α-synuclein load is associated with amyloid-β plaque burden in a subset of Parkinson's disease patients
Tammaryn Lashley et al.
ACTA NEUROPATHOLOGICA (2008)
Validation of the neuropathologic criteria of the Third Consortium for Dementia with Lewy bodies for prospectively diagnosed cases
Hiroshige Fujishiro et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
Mariese A. Hely et al.
MOVEMENT DISORDERS (2008)
Neuropsychological characteristics of dementia with Lewy bodies and Parkinson's disease with dementia: Differentiation, early detection, and implications for mild cognitive impairment and biomarkers
Alexander I. Troster
NEUROPSYCHOLOGY REVIEW (2008)
Clinical diagnostic criteria for dementia associated with Parkinson's disease
Murat Emre et al.
MOVEMENT DISORDERS (2007)
Irreversible motor impairment in young addicts - ephedrone, manganism or both?
K. Sikk et al.
ACTA NEUROLOGICA SCANDINAVICA (2007)
Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model
Yasumasa Yoshiyama et al.
NEURON (2007)
Differences in neuropathologic characteristics across the Lewy body dementia spectrum
C. Ballard et al.
NEUROLOGY (2006)
Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry
Heiko Braak et al.
ACTA NEUROPATHOLOGICA (2006)
Cognitive profiles of individual patients with Parkinson's disease and dementia: Comparison with dementia with Lewy bodies and Alzheimer's disease
CC Janvin et al.
MOVEMENT DISORDERS (2006)
Diagnosis and management of dementia with Lewy bodies - Third report of the DLB consortium
IG McKeith et al.
NEUROLOGY (2005)
Aβ deposition is associated with enhanced cortical α-synuclein lesions in Lewy body diseases
O Pletnikova et al.
NEUROBIOLOGY OF AGING (2005)
Amygdalar and hippocampal MRI volumetric reductions in Parkinson's disease with dementia
C Junqué et al.
MOVEMENT DISORDERS (2005)
Cognitive status correlates with neuropathologic stage in Parkinson disease
H Braak et al.
NEUROLOGY (2005)
The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia
JJ Zarranz et al.
ANNALS OF NEUROLOGY (2004)
Cognitive dysfunction and dementia in Parkinson's disease
JLW Bosboom et al.
JOURNAL OF NEURAL TRANSMISSION (2004)
Stages in the development of Parkinson's disease-related pathology
H Braak et al.
CELL AND TISSUE RESEARCH (2004)
α-synuclein locus triplication causes Parkinson's disease
AB Singleton et al.
SCIENCE (2003)
Regional cerebral blood flow in Parkinson's disease with and without dementia
M Firbank et al.
NEUROIMAGE (2003)
Fluctuations in attention - PD dementia vs DLB with parkinsonism
CG Ballard et al.
NEUROLOGY (2002)
Relationships among the metabolic patterns that correlate with mnemonic, visuospatial, and mood symptoms in Parkinson's disease
MJ Mentis et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease
HI Hurtig et al.
NEUROLOGY (2000)
Hallucinations in Parkinson's disease -: Prevalence, phenomenology and risk factors
G Fénelon et al.
BRAIN (2000)
Macular microcirculation characteristics in Parkinson's disease evaluated by OCT-Angiography: a literature review
Evita Evangelia Christou et al.
SEMINARS IN OPHTHALMOLOGY